Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP919050.RA3COeSOPctyYYS1o5Ktksy7lOR0hXRrv8lpnR3R39oS4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP919050.RA3COeSOPctyYYS1o5Ktksy7lOR0hXRrv8lpnR3R39oS4130_assertion type Assertion NP919050.RA3COeSOPctyYYS1o5Ktksy7lOR0hXRrv8lpnR3R39oS4130_head.
- NP919050.RA3COeSOPctyYYS1o5Ktksy7lOR0hXRrv8lpnR3R39oS4130_assertion description "[Several studies have reported that a high expression ratio of HOXB13 to IL17BR predicts tumor recurrence in node-negative, estrogen receptor (ER) alpha-positive breast cancer patients treated with tamoxifen.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP919050.RA3COeSOPctyYYS1o5Ktksy7lOR0hXRrv8lpnR3R39oS4130_provenance.
- NP919050.RA3COeSOPctyYYS1o5Ktksy7lOR0hXRrv8lpnR3R39oS4130_assertion evidence source_evidence_literature NP919050.RA3COeSOPctyYYS1o5Ktksy7lOR0hXRrv8lpnR3R39oS4130_provenance.
- NP919050.RA3COeSOPctyYYS1o5Ktksy7lOR0hXRrv8lpnR3R39oS4130_assertion SIO_000772 18499701 NP919050.RA3COeSOPctyYYS1o5Ktksy7lOR0hXRrv8lpnR3R39oS4130_provenance.
- NP919050.RA3COeSOPctyYYS1o5Ktksy7lOR0hXRrv8lpnR3R39oS4130_assertion wasDerivedFrom befree-20150227 NP919050.RA3COeSOPctyYYS1o5Ktksy7lOR0hXRrv8lpnR3R39oS4130_provenance.
- NP919050.RA3COeSOPctyYYS1o5Ktksy7lOR0hXRrv8lpnR3R39oS4130_assertion wasGeneratedBy ECO_0000203 NP919050.RA3COeSOPctyYYS1o5Ktksy7lOR0hXRrv8lpnR3R39oS4130_provenance.